5,61 There are differences in the affinity and residence times of estrogens and the SERMs
"With the positive results across five Phase 3 studies, we now have the clinical data package to support global submissions for retatrutide and look forward to working with regulators as they evaluate this first-of-its-kind medicine, said Kenneth Custer, Ph.D., executive vice president and president, Lilly Cardiometabolic Health
analyzed the data and wrote the manuscript with inputs from all co-authors
resM has no published weight loss data from completed clinical trials
Size Exclusion Chromatography: The Aggregation Requirement One analytical dimension that receives less attention in general-audience coverage, but is mandatory for GLP-1 drug products, is aggregation testing by size exclusion chromatography (SEC)
These medications work by mimicking a hormone called glucagon-like peptide-1 (GLP-1), which plays a crucial role in regulating blood sugar levels and appetite
)
